The COVID -19 pandemic has created an unprecedented challenge for pharmaceutical companies. Being a heavily regulated industry, it is important to maintain the required GxP and high-quality standards. In this scenario, postponing all the regulatory audits indefinitely, is not a viable option. Effective continued oversite is required to maintain the quality standards of the products. So, the regulatory bodies are now turning to Virtual Audits.
Virtual Audits is a relatively new concept. USFDA has also just released the guidelines for them in April, 2021. This interactive forum will help us understand the difference between both types of audits and how can Virtual Audits be used as an effective tool to complement physical audits in the future.
Technology has been implemented at a brisk pace in the last 12 months. The best way to remain compliant is to adopt new innovations in our organisation. Let's discuss how can we leverage technological advancement to improve our regulatory compliance and become more efficient.
Eminence Business Media, brings this open forum, "Pharma Audit Readiness- Virtual & Physical", where you can put up your questions, participate in debates and get answers for the challenges faced by the teams and collectively implement the learnings.